Alpha-synuclein (SNCA) polymorphisms exert protective effects on memory after mild traumatic brain injury

Area of Science:

• Neuroscience
• Genetics
• Traumatology

Background:

• Mild traumatic brain injury (mTBI) frequently leads to cognitive impairments, including attention and memory deficits.
• The alpha-synuclein (SNCA) gene is implicated in dopaminergic pathways and neurological conditions, suggesting a potential role in mTBI-related cognitive outcomes.

Purpose of the Study:

• To investigate the association between single nucleotide polymorphisms (SNPs) in the SNCA gene and cognitive performance in individuals who have sustained an mTBI.
• To identify potential genetic markers that may influence memory and attention recovery after mTBI.

Main Methods:

• A cohort of 91 mTBI patients and 86 healthy controls underwent cognitive testing one month post-injury.
• Genotyping was performed for 13 common SNPs within the SNCA gene.
• Cognitive assessments included measures of baseline intellectual function, attention, and memory.

Main Results:

• mTBI patients showed significant differences in memory performance compared to controls (p=0.001 and 0.002).
• No significant differences were observed in baseline intellectual function or attentional tasks between groups.
• The SNCA promoter SNP rs1372525 demonstrated a protective association with memory, where the A (minor) allele conferred better memory performance in mTBI patients (p=0.006 and 0.029).

Conclusions:

• SNCA gene polymorphisms, specifically rs1372525, are associated with memory outcomes following mild traumatic brain injury.
• These findings suggest a potential genetic component in the pathophysiology of cognitive deficits after mTBI.
• Further research is warranted to explore the role of SNCA in mTBI recovery and potential therapeutic targets.